{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:02:13Z","timestamp":1791925333011,"version":"4.3.4"},"reference-count":29,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"unspecified","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Qual"],"accepted":{"date-parts":[[2024,2,14]]},"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Iron deficiency anaemia (IDA) is common in patients with heart failure (HF) and is associated with advanced HF and increased mortality. Intravenous iron supplementation increases exercise tolerance, improves quality of life, and decreases symptoms among patients with HF with reduced ejection fraction (HFrEF) and iron deficiency. Despite this, many patients are not screened or treated for IDA. We aimed to increase rates of screening and treatment of IDA among HF patients through the introduction of curated materials to aid HF clinicians with appropriate screening and treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a retrospective chart review to identify the baseline number of HFrEF patients screened and treated for IDA at two ambulatory cardiology clinics in Toronto, Ontario. A quality improvement initiative was then introduced, which consisted of education and curated materials to aid clinicians in the screening and treatment of IDA among HFrEF patients. The proportion of patients screened and treated for IDA preintervention and postintervention were compared using \u03c7<jats:sup>2<\/jats:sup> tests of Independence.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In the preintervention cohort, 36.3% (n=45) of patients with anaemia were screened for IDA. Among those screened, 64.4% (n=29) had IDA. Only 17.2% (n=5) of these were treated with IV iron. After implementation of the quality improvement initiative, 90.9% (n=60) of patients with anaemia were screened for IDA (p&lt;0.001) and 90.3% (n=28) of those with IDA were treated with IV iron (p&lt;0.001).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The introduction of curated materials to aid clinicians was associated with increased rates of screening and treatment of IDA among ambulatory HFrEF patients. Further work is required to identify barriers and implement strategies to increase screening and treatment rates of IDA among HFrEF patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjoq-2023-002584","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T11:50:33Z","timestamp":1708689033000},"page":"e002584","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Increasing rates of screening and treatment of iron deficiency in ambulatory patients with heart failure with reduced ejection fraction: a quality improvement cohort study"],"prefix":"10.1136","volume":"13","author":[{"given":"Mena","family":"Gewarges","sequence":"first","affiliation":[{"name":"Division of Cardiology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9295-4703","authenticated-orcid":false,"given":"Roslyn","family":"Mainland","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Queen's University, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Sklar","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Gentilin","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"McLean","sequence":"additional","affiliation":[{"name":"McMaster University Michael G DeGroote School of Medicine, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4292-3105","authenticated-orcid":false,"given":"Omar I","family":"Hajjaj","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mali","family":"Worme","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer","family":"Lalonde","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raumil","family":"Patel","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5562-9020","authenticated-orcid":false,"given":"Yulia","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6133-0677","authenticated-orcid":false,"given":"Jeannie","family":"Callum","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Pathology and Molecular Medicine, Kingston Health Sciences Centre, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Poon","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,2,23]]},"reference":[{"key":"2025083114355033000_13.1.e002584.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.01.017"},{"key":"2025083114355033000_13.1.e002584.2","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00392-016-1073-y","article-title":"Prevalence and clinical impact of iron deficiency and anaemia among outpatients with chronic heart failure: the prep Registry","volume":"106","author":"von Haehling","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"2025083114355033000_13.1.e002584.3","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.161"},{"key":"2025083114355033000_13.1.e002584.4","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/ehf2.13265","article-title":"Iron deficiency in heart failure","volume":"8","author":"Loncar","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2025083114355033000_13.1.e002584.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2017.08.022"},{"key":"2025083114355033000_13.1.e002584.6","first-page":"36","article-title":"Iron deficiency in heart failure: an overview","volume":"7","author":"von Haehling","year":"2019","journal-title":"JACC: Heart Failure"},{"key":"2025083114355033000_13.1.e002584.7","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/ejhf.1305","article-title":"Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European society of cardiology heart failure guidelines into clinical practice","volume":"20","author":"McDonagh","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2025083114355033000_13.1.e002584.8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijcard.2015.11.178","article-title":"The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. results from the studies investigating Co-morbidities aggravating heart failure","volume":"205","author":"Ebner","year":"2016","journal-title":"Int J Cardiol"},{"key":"2025083114355033000_13.1.e002584.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.04.061"},{"key":"2025083114355033000_13.1.e002584.10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.114.001100"},{"key":"2025083114355033000_13.1.e002584.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2011.08.003"},{"key":"2025083114355033000_13.1.e002584.12","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hft083"},{"key":"2025083114355033000_13.1.e002584.13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu385"},{"key":"2025083114355033000_13.1.e002584.14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908355"},{"key":"2025083114355033000_13.1.e002584.15","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfs017"},{"key":"2025083114355033000_13.1.e002584.16","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.473"},{"key":"2025083114355033000_13.1.e002584.17","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.823"},{"key":"2025083114355033000_13.1.e002584.18","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ejhf.236","article-title":"Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral","volume":"17","author":"McDonagh","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2025083114355033000_13.1.e002584.19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.5427"},{"key":"2025083114355033000_13.1.e002584.20","doi-asserted-by":"crossref","first-page":"106345","DOI":"10.1016\/j.phrs.2022.106345","article-title":"Comparative efficacy of intravenous and oral iron supplements for the treatment of iron deficiency in patients with heart failure: a network meta-analysis of randomized controlled trials","volume":"182","author":"Mei","year":"2022","journal-title":"Pharmacol Res"},{"key":"2025083114355033000_13.1.e002584.21","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"2025083114355033000_13.1.e002584.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.12.012"},{"key":"2025083114355033000_13.1.e002584.23","unstructured":"Team RC . R: A language and environment for statistical computing. R Found Stat Comput 2021."},{"key":"2025083114355033000_13.1.e002584.24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjquality.u209822.w4076","article-title":"Improving the management of iron deficiency in ambulatory heart failure patients","volume":"5","author":"Hayward","year":"2016","journal-title":"BMJ Qual Improv Report"},{"key":"2025083114355033000_13.1.e002584.25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nefro.2016.03.001","article-title":"Iron deficiency in patients with congestive heart failure: a medical practice that requires greater attention","volume":"36","author":"Belmar Vega","year":"2016","journal-title":"Nefrologia"},{"key":"2025083114355033000_13.1.e002584.26","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/j.ijcard.2013.01.249","article-title":"The missed opportunities to diagnose and treat iron deficiency in patients hospitalized with heart failure","volume":"168","author":"Silverberg","year":"2013","journal-title":"Int J Cardiol"},{"key":"2025083114355033000_13.1.e002584.27","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200826060-00001"},{"key":"2025083114355033000_13.1.e002584.28","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-018-0815-3","article-title":"Cost-of-illness studies in heart failure: a systematic review 2004-2016","volume":"18","author":"Lesyuk","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"2025083114355033000_13.1.e002584.29","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s41669-022-00341-7","article-title":"Budget impact of intravenous iron therapy with Ferric Carboxymaltose in patients with chronic heart failure with reduced ejection fraction (Hfref) and iron deficiency in Switzerland","volume":"6","author":"Brock","year":"2022","journal-title":"Pharmacoecon Open"}],"container-title":["BMJ Open Quality"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjoq-2023-002584","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T21:35:58Z","timestamp":1756676158000},"score":1,"resource":{"primary":{"URL":"https:\/\/qir.bmj.com\/lookup\/doi\/10.1136\/bmjoq-2023-002584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,2,23]]},"published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1136\/bmjoq-2023-002584"],"URL":"https:\/\/doi.org\/10.1136\/bmjoq-2023-002584","relation":{},"ISSN":["2399-6641"],"issn-type":[{"value":"2399-6641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]}}}